Page 6 of lupin

Lupin, Lupin Limited, COPD, COPD management, healthcare news, pharma news,

Lupin launches fixed-dose triple combination drug for COPD in India

The product is available in a single-strength fixed dose, with a recommended once-daily dosage.

November 24, 2023 11:11 IST

USFDA, USFDA approval, Lupin, Lupin limited, healthcare news, pharma news, news, pharma news,

USFDA gives tentative approval to Lupin’s Type 2 diabetes drug

Canagliflozin Tablets (RLD Invokana) had estimated annual sales of USD 561 million in the U.S. (IQVIA MAT September 2023).

November 24, 2023 10:55 IST

Lupin, Lupin Limited, generic formulations, sleep disorders, healthcare news,

Lupin gets USFDA nod for its solution to treat ocular pain

Bromfenac Ophthalmic Solution (RLD Prolensa) had estimated annual sales of USD 185 million in the U.S. (IQVIA MAT September 2023).

November 24, 2023 09:56 IST

USFDA, Lupin, Lupin Limited, cholesterol drugs, healthcare news, pharma news,

USFDA gives nod to Lupin’s cholesterol-lowering drug

Pitavastatin Tablets (RLD Livalo) had estimated annual sales of USD 298 million in the U.S. (IQVIA MAT September 2023).

November 22, 2023 08:53 IST

Lupin, Lupin Limited, USFDA, generic formulation, healthcare news, pharma news,

USFDA gives nod to Lupin’s generic muscle relaxant formulation in United States

Rocuronium Bromide Injection (RLD: Zemuron) had estimated annual sales of USD 54 million in the U.S. (IQVIA MAT August 2023).

November 9, 2023 13:42 IST

USFDA grants tentative approval to Lupin’s generic formulation for type 2 diabetes

This product will be manufactured at Lupin’s Pithampur facility in India.

November 8, 2023 11:51 IST

Lupin gets EIR from USFDA for its Mandideep Unit-2 manufacturing facility

The inspection closed with the facility receiving an inspection classification of “No Action Indicate” (NAI).

November 1, 2023 15:31 IST

USFDA gives tentative approval to Lupin’s prostate cancer tablets

This product will be manufactured at Lupin’s Pithampur facility in India.

October 17, 2023 11:22 IST

USFDA gives tentative approval to Lupin’s generic formulation to treat excessive daytime sleepiness

Lupin is exclusive first-to-file and may be eligible to receive a 180-day exclusivity period at product launch, the company stated.

October 13, 2023 12:50 IST

USFDA gets tentative approval for tablets to treat low sodium levels in heart patients

This product will be manufactured at Lupin’s Nagpur facility in India.

October 6, 2023 11:18 IST

Lupin launches patient support program for diabetes management

Individuals living with the illness are at increased risk of developing multiple complications, including heart disease, stroke, kidney ailments, nerve…

October 4, 2023 14:12 IST

Lupin gets EIR from USFDA for its Nagpur Unit-1 Manufacturing Facility

The U.S. FDA has determined that the inspection classification of the facility is Voluntary Action Indicated (VAI).

September 29, 2023 15:54 IST

Lupin acquires five brands from Menarini to strengthen its therapy portfolio in India

“This strategic acquisition for the Indian market marks a significant step forward for Lupin as it continues to expand its…

September 22, 2023 14:28 IST

Lupin gets USFDA approval for its chronic lung disorder capsules

Pirfenidone Capsules (RLD Esbriet) had estimated annual sales of USD 95 million in the U.S. (IQVIA MAT June 2023).

August 31, 2023 10:13 IST

CDSCO, drug alert, DCGI, spurious drugs, drug quality, healthcare news, pharma news

Lupin acquires brands from Boehringer Ingelheim to expand Diabetes portfolio in India

This acquisition strengthens Lupin’s commitment to providing superior treatment options for patients navigating the complexities of diabetes, it claimed.

August 18, 2023 15:51 IST

Lupin Launches inhaler powder for COPD in the United States

Tiotropium Bromide Inhalation Powder (Reference Product Spiriva HandiHaler) had estimated annual sales of USD 1,264 million in the US (IQVIA…

August 18, 2023 08:00 IST

Lupin gets USFDA nod for its anti-inflammatory eye drop

This product will be manufactured at Lupin’s Pithampur facility in India.

August 17, 2023 08:00 IST

USFDA approves Lupin’s extended-release tablets to treat chest pain

According to the company’s press statement, the approval is to market a generic equivalent of Toprol-XL Tablets, 25 mg, 50…

August 17, 2023 07:00 IST

Related News

H-1B visa, H-1B visa ban, H-1B visa program, temporary visa program, foreign worker program

US lawmaker proposes complete ban of H-1B visa program

Meta’s $14 billion AI hire Alexandr Wang finds Mark Zuckerberg’s micromanagement ‘suffocating’: Report

Your job appointment letter and salary slip are set to change with new labour laws — what to expect

Your job appointment letter and salary slip will change soon — here’s what new labour laws bring

FIIs defy sector gloom to buy this power stock: What’s Driving the 400% Profit Surge?

Not Adani, Not Tata: The one power stock FIIs are aggressively buying now

Maharashtra local body election result 2025 date and time: When and where to check civic poll results

Range balls vs real balls

Sports5 hr ago

Golfers experience a stark contrast between their performance on the driving range and on the course. This is due to the forgiving range balls and the unforgiving real balls. To improve, golfers should use the range with intention and embrace the challenges of playing with real balls.

View all shorts